U.S. makes investment in new HIV prevention drug
September 7, 2025
13,290
698
98
5.99%
Search the Record
IndexedEvery word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
Npr Episodes Around September 7, 2025
See what was published immediately before and after this episode.
1:04Now PlayingU.S. makes investment in new HIV prevention drug
YouTube Description
as posted by the channelThe U.S. announced Thursday it's helping to procure a new HIV prevention drug — and to give it to as many as 2 million people in lower-income countries over the next three years. The drug, called lenacapavir, has been hailed as a game-changer.
Clinical trials showed just two injections a year provide almost complete protection against contracting HIV. The U.S. says it’s going to work with the drug maker, Gilead Sciences, and the Global Fund, the international financing organization, to get lenacapavir to the countries hardest hit by HIV. The Trump administration says the approach of buying commodities and focusing on medical breakthroughs will be the model for its global health work in the future.
• Read or listen to"Why the medical community is thrilled by U.S. support for a 'breakthrough' HIV drug" at
------------------------------------------------------
Follow NPR elsewhere, too:
Links & Promotions
Guests & Subjects Covered
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.